Abstract:Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by the complex proliferation of the pulmonary vascular endothelium and progressive pulmonary vascular remodeling. CD4(+)CD25(+) regulatory T cells (Tregs) have been the focus of numerous studies into PAH. The present study aimed to investigate the role and mechanisms of Tregs in hypoxia-induced PAH. A total of 60 male mice were divided at random into three groups: Normoxia group, hypoxia control group and Tregs group. Measurements were obtained of the right ventricle systolic pressure (RVSP) and the Fulton's index; in addition, the mRNA and protein expression of pro-inflammatory cytokines including monocyte chemotactic protein 1 (MCP-1), interleukin (IL)-1 and IL-6, as well as the anti-inflammatory cytokine IL-10 in the lungs were determined by reverse transcription quantitative polymerase chain reaction and western blot analysis in vivo. Human pulmonary artery smooth muscle cells (HPASMCs) were cultured under hypoxic condition with or without Tregs for 48 h, and the proliferation rate and cell cycle of HPASMCs were determined. In addition, the protein levels of phosphorylated (p)-Akt and p-extracellular signal-regulated kinase (ERK) were measured in HPASMCs in vitro. The results showed that Treg treatment significantly reduced the increased the hypoxia-induced RVSP and Fulton's index, decreased pro-inflammatory cytokine expression as well as enhanced IL-10 levels in vivo. Furthermore, Treg treatment significantly reduced HPASMCs proliferation and the expression of cyclin D1, cyclin-dependent kinase (CDK)4, p-Akt and p-ERK, as well as increased p27 expression in vitro. In conclusion, the results of the present study indicated that Tregs protected against hypoxia-induced PAH in mice; the mechanisms of which may proceed via the suppression of the inflammatory response, as Tregs were found to enhance anti-inflammatory cytokine levels, inhibit HPASMCs proliferation and regulate the cell cycle. These results therefore indicated that Tregs may be a potential novel target for the treatment of PAH.

Mammalian Target of Rapamycin Overexpression Antagonizes Chronic Hypoxia-Triggered Pulmonary Arterial Hypertension Via the Autophagic Pathway.

Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension.

Pathogenic Role of Mtorc1 and Mtorc2 in Pulmonary Hypertension

A Critical Role of the Mtor/eif2α Pathway in Hypoxia-Induced Pulmonary Hypertension

Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension.

Mtor Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis

mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy

Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension Via Mtorc1 Signaling

β-arrestin1 inhibits hypoxic injury-induced autophagy in human pulmonary artery endothelial cells via the Akt/mTOR signaling pathway

Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-mediated FAK Phosphorylation

Inhibition of Mtor Attenuates Store-Operated Ca2+ Entry in Cells from Endarterectomized Tissues of Patients with Chronic Thromboembolic Pulmonary Hypertension

PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis

Mir-100 Suppresses Mtor Signaling in Hypoxia-Induced Pulmonary Hypertension in Rats

Activation of AMPK Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension by Suppression of NF-κB-mediated Autophagy Activation.

The HIF-1 alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy

Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice.

mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors

Upregulation of Angiomotin-Like 2 Ameliorates Experimental Pulmonary Arterial Hypertension by Inactivating YAP1 Signaling

Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs

Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.